News • (B)eating cancer
Bacteria to consume tumours from the inside out
A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumours from the inside out.
Cancer
News • Treatment approach
How to improve cancer cure rates? “Kick it while it’s down”
Although tumours may at first shrink under therapy, they often regrow or even become resistant. A new study suggests switching to a second treatment while the tumour is still responding to the first.
News • Cancer “chronotherapy”
Beating cancer by the clock: Why the time of day matters for radiotherapy
Radiotherapy is more effective when administered at the right time of day, according to new research. This discovery opens the door to cancer “chronotherapy”, the researchers hope.
News • AI detects unseen connection
Insulin resistance identified as risk factor for cancer
Not just linked to diabetes: For the first time, researchers demonstrated that insulin resistance is a risk factor for 12 types of cancer, including uterine and breast cancer.
Article • Digital pathology and AI
Finding new biomarkers to match the biological complexity of cancer
Advances in artificial intelligence and multimodal data integration are poised to revolutionise cancer diagnostics – but significant challenges remain before these technologies can be routinely deployed in clinical practice. Professor Manuel Salto-Tellez outlined the steps needed to bridge the gap between complex tumour biology and the relatively simple biomarkers currently available, speaking…
News • Research on metastasis mechanism
How ovarian cancer hijacks abdominal cells as an invasion force
Due to its rapid spread in the abdomen, ovarian cancer is often only detected at an advanced stage. Now, scientists have discovered how this cancer takes advantage of other cells for metastasis.
News • CTNNB1 in focus
Mutation strength may hold key to personalized cancer treatment
Not all cancer mutations are equal: new research shows that a single mutation hotspot can generate a rich diversity of tumour behaviours. This could lead to more personalised cancer treatments.
News • Two tracers, one target
Dual PET approach for personalized head and neck cancer treatment
Beyond "one-size-fits-all": A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research.
News • PRO in oncology
Giving patients a voice: How self-reported data improves cancer treatment
Integrating the patient’s voice: A new study shows access to patient-reported outcome (PRO) data improves the consistency of the evaluation of treatment-related side effects in patients with cancer.
News • Soft tissue ablation
Adapting eye-laser technology to remove cancer
Scientists have shown that a type of laser similar to the one currently used in routine eye surgery could one day help surgeons remove unwanted tissues, such as tumours, with unprecedented accuracy.
News • Exploring metastatic potential
AI predicts risk of cancer metastases
Why do some tumours spread while others remain localised? Using colon cancer cells, scientists pinpointed the criteria that influence metastasis risk, and identified a way to assess its probability.
News • Plasma protein profiling
Blood test spots cancer in patients with unspecific symptoms
Non-specific symptoms such as fatigue, pain or weight loss can be caused by cancer, another serious condition or something completely harmless. A blood test can help provide relevant information.
News • Systemic mechanism discovered
Chemotherapy rewires gut bacteria to curb metastasis
Chemotherapy does more than kill cancer cells: It reshapes the gut microbiome, making the body less permissive to metastasis. This finding opens new avenues for adjuvant strategies.
News • Anthracycline cardiotoxicity
Common chemo drug increases risk of heart damage, study finds
A widely used chemotherapy drugs used in cancer treatments can cause heart damage, new research shows. This could be used to adapt treatment regimens - especially in patients with high blood pressure.
News • Focus on tumor STAT1 acetylation
How cancer cells learn under pressure to evade immunotherapy
Immunotherapy has been hailed as a breakthrough in cancer treatment. But new research reveals: under sustained treatment pressure, cancer does not simply weaken — it adapts, learns, and fights back.
News • Phase III trial
Proton therapy shows survival benefit for patients with head and neck cancers
A new study shows a significant survival benefit for patients with oropharyngeal cancers treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).
News • Clinically validated framework
AI helps detect kidney cancer faster
A novel machine-learning-based solution analyses CT images and helps radiologists detect both malignant and benign lesions in the kidney more quickly and reliably.
News • Tissue sample analysis
Demographic bias creeps into pathology AI, study finds
A sample of inequality: A new study shows that AI models can infer demographic information from pathology slides, leading to bias in cancer diagnosis among different populations.
News • Prevalence, changes and associated factors
How to reduce the risk of head and neck lymphedema after radiotherapy
Researchers have discovered that low physical activity is associated with a higher risk of lymphedema. They have also noted that a lymph scanner objectively measures changes in the condition.
News • Lung cancer CT notification
Breast cancer: Keep CALM – and coordinate your screenings
Many women over 50 schedule mammograms for breast cancer but miss out on CT lung cancer screenings they're also eligible for. Targeted outreach coul help change this, a new study shows.
News • Insights on IDH mutated gliomas
Brain cancer: why early treatment is not always the best course
IDH mutated gliomas are slow-growing brain tumors with a relatively good prognosis. A new study shows that many patients reveal measurable cognitive impairment in the first year after treatment.
News • Benefits for survival and employment
Breast cancer: study explores economic aspects of radiotherapy
While saving lives remains the primary goal, a new study explores how radiation therapy also helps breast cancer survivors return to work. Policymakers should factor this in, the researchers argue.
News • In vitro disease models
'Intrepid' research to advance cancer therapies
A major new initiative aims to enable the development of advanced, specific and highly reproducible human in vitro models for greater understanding of disease and the acceleration of new medicines.
News • Targeted drug activation
Ultrasound-triggered chemotherapy to reduce side-effects
Researchers explore how ultrasound waves can be used to activate chemotherapy drugs only in targeted areas, offering a new path toward safer, more effective cancer treatment.
Article • Hengrui Pharma charts its global strategy at ESMO
Meet the Chinese company advancing European oncology
Hengrui, one of China's leading pharmaceutical companies, is preparing to bring its cancer therapies to international markets. At the ESMO congress in Berlin, Yuting (Shelley) Liu, Head of China Business Development and Strategy of Hengrui Pharma, shared insights into how the company is translating decades of Chinese market experience into a global oncology strategy.
